ClinicalTrials.Veeva

Menu
A

Albert Einstein College of Medicine | Division of Nephrology

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Paclitaxel
Carboplatin
Cyclophosphamide
Zidovudine
Erlotinib Hydrochloride
Glucose
Lenalidomide
Ixabepilone
Diazoxide
Tenofovir Disoproxil Fumarate

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

6 of 171 total trials

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

The primary purpose of this study is to measure the response rate in participants with the myeloproliferative neoplasms (MPNs), polycythemia vera (PV...

Active, not recruiting
Neoplasms, Hematologic
Drug: 120 mg LY2784544

This 2 x 2 factorial, randomized, double-blind, placebo-controlled trial will test two interventions: directly observed medication therapy, and long-...

Active, not recruiting
Opioid-use Disorder
Tobacco Use Disorder
Behavioral: Self Administered Therapy
Drug: Long-Term Varenicline

This is a randomized, blinded, non-comparative, two-arm Phase 2 clinical trial to assess the efficacy and safety of AGEN2034 administered with placeb...

Active, not recruiting
Cervical Cancer
Drug: AGEN2034
Drug: AGEN1884

This project proposes to use telemedicine-delivered cognitive-behavioral therapy (CBT) enhanced with continuous glucose monitor (CGM) review to targe...

Enrolling
Type 1 Diabetes
Behavioral: Cognitive Behavioral Therapy for Diabetes Distress (CBT-DD) with Continuous Glucose Monitoring
Device: Continuous Glucose Monitoring (CGM)

The purpose of this study is to use precision medicine in the form of a vaccine, a mutation-derived tumor antigen vaccine (MTA-based vaccine) in comb...

Active, not recruiting
Glioblastoma
Biological: Peptides
Drug: Poly-ICLC

This project will evaluate a telemedicine-delivered, Unified Protocol for Cognitive-Behavioral Therapy (UP-CBT) enhanced with continuous glucose moni...

Enrolling
Diabetes
Type 1 Diabetes
Device: Continuous Glucose Monitoring (CGM)
Behavioral: Unified protocol for cognitive behavioral therapy (UP-CBT)

Trial sponsors

Albert Einstein College of Medicine logo
National Cancer Institute (NCI) logo
National Institute of Allergy and Infectious Diseases (NIAID) logo
Montefiore Medicine Academic Health System logo
ECOG-ACRIN Cancer Research Group logo
Duke University logo
Lilly logo
L
Memorial Sloan Kettering Cancer Center (MSK) logo
Mount Sinai Health System logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems